GMO U.S. Value ETF (NYSEARCA:GMOV – Get Free Report) saw a significant decrease in short interest in August. As of August 14th, there was short interest totaling 509 shares, a decrease of 90.1% from the July 30th total of 5,166 shares. Based on an average trading volume of 10,463 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the company’s shares are short sold.
GMO U.S. Value ETF Stock Performance
NYSEARCA:GMOV remained flat at $32.77 during trading hours on Tuesday. 4,131 shares of the company’s stock traded hands, compared to its average volume of 16,090. The firm has a fifty day simple moving average of $31.18 and a 200 day simple moving average of $29.89. GMO U.S. Value ETF has a one year low of $25.66 and a one year high of $32.82. The company has a market capitalization of $104.86 million, a P/E ratio of 12.08 and a beta of 0.62.
Institutional Trading of GMO U.S. Value ETF
Several hedge funds have recently added to or reduced their stakes in GMOV. Pathway Financial Advisors LLC acquired a new position in GMO U.S. Value ETF during the second quarter worth about $246,000. Essential Partners LLC lifted its stake in shares of GMO U.S. Value ETF by 8.6% in the 1st quarter. Essential Partners LLC now owns 60,238 shares of the company’s stock valued at $1,692,000 after purchasing an additional 4,774 shares during the last quarter. Fifth Third Bancorp acquired a new position in GMO U.S. Value ETF in the 1st quarter valued at $84,000. Kestra Private Wealth Services LLC bought a new stake in shares of GMO U.S. Value ETF in the first quarter valued at about $333,000. Finally, MML Investors Services LLC acquired a new position in GMO U.S. Value ETF in the fourth quarter worth about $1,794,000.
About GMO U.S. Value ETF
The GMO US Value ETF (GMOV) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, investing primarily in US equity securities. The fund seeks to identify undervalued US stocks using proprietary quantitative methods, capitalizing on perceived market dislocations GMOV was launched on Oct 28, 2024 and is issued by GMO.
Featured Articles
- Five stocks we like better than GMO U.S. Value ETF
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
- StoneX: Too Far Too Fast?
- DICK’s Sporting Goods Faces Pain Now for a Bigger Prize
Receive News & Ratings for GMO U.S. Value ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GMO U.S. Value ETF and related companies with MarketBeat.com's FREE daily email newsletter.
